Marsh & McLennan shows strong growth and dividend potential despite sector challenges, trading at a discount.

Marsh & McLennan (MRSH) is experiencing solid organic revenue growth and strong earnings per share (EPS) performance, maintaining an attractive dividend profile even amid challenges in the insurance sector. The stock trades at a forward price-to-earnings ratio of 14.9, significantly below its 10-year average of 21.9, indicating a 26% discount to its fair value. With a strong A- credit rating from S&P, MRSH is well-positioned for continued acquisitions and aims to grow dividends by at least 9% annually. Key risks include potential declines in commercial insurance rates and exposure to litigation, but MRSH remains a core holding for investors focused on dividends and long-term growth.